Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 3 |
2009 | 2 |
2010 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Capsule endoscopy with retention of the capsule in a duodenal diverticulum.
Endoscopy. 2008 Sep;40 Suppl 2:E247-8. doi: 10.1055/s-2008-1077563. Epub 2008 Nov 7.
Endoscopy. 2008.
PMID: 18991223
No abstract available.
Bleeding Dieulafoy lesions of the small bowel: a systematic study on the epidemiology and efficacy of enteroscopic treatment.
Dulic-Lakovic E, Dulic M, Hubner D, Fuchssteiner H, Pachofszky T, Stadler B, Maieron A, Schwaighofer H, Püspök A, Haas T, Gahbauer G, Datz C, Ordubadi P, Holzäpfel A, Gschwantler M; Austrian Dieulafoy-bleeding Study Group.
Dulic-Lakovic E, et al. Among authors: ordubadi p.
Gastrointest Endosc. 2011 Sep;74(3):573-80. doi: 10.1016/j.gie.2011.05.027. Epub 2011 Jul 29.
Gastrointest Endosc. 2011.
PMID: 21802676
Item in Clipboard
Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response.
Ferenci P, Laferl H, Scherzer TM, Gschwantler M, Maieron A, Brunner H, Stauber R, Bischof M, Bauer B, Datz C, Löschenberger K, Formann E, Staufer K, Steindl-Munda P; Austrian Hepatitis Study Group.
Ferenci P, et al.
Gastroenterology. 2008 Aug;135(2):451-8. doi: 10.1053/j.gastro.2008.04.015. Epub 2008 May 27.
Gastroenterology. 2008.
PMID: 18503773
Clinical Trial.
Item in Clipboard
A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3.
Ferenci P, Brunner H, Laferl H, Scherzer TM, Maieron A, Strasser M, Fischer G, Hofer H, Bischof M, Stauber R, Gschwantler M, Steindl-Munda P, Staufer K, Löschenberger K; Austrian Hepatitis Study Group.
Ferenci P, et al.
Hepatology. 2008 Jun;47(6):1816-23. doi: 10.1002/hep.22262.
Hepatology. 2008.
PMID: 18454510
Clinical Trial.
Item in Clipboard
Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response.
Ferenci P, Laferl H, Scherzer TM, Maieron A, Hofer H, Stauber R, Gschwantler M, Brunner H, Wenisch C, Bischof M, Strasser M, Datz C, Vogel W, Löschenberger K, Steindl-Munda P; Austrian Hepatitis Study Group.
Ferenci P, et al.
Gastroenterology. 2010 Feb;138(2):503-12, 512.e1. doi: 10.1053/j.gastro.2009.10.058. Epub 2009 Nov 10.
Gastroenterology. 2010.
PMID: 19909752
Clinical Trial.
Item in Clipboard
Peginterferon plus ribavirin over two years may be successful in patients with chronic hepatitis C and a very slow virologic response.
Ordubadi P, Gschwantler M.
Ordubadi P, et al.
Scand J Gastroenterol. 2009;44(9):1150-1. doi: 10.1080/00365520903104434.
Scand J Gastroenterol. 2009.
PMID: 19593689
No abstract available.
Item in Clipboard
Cite
Cite